36.01

3.12% -1.16

Janux Therapeutics Inc (JANX)

Overview News Price History Option Chain Financials Discussions Forecast

Janux Therapeutics Inc stock is traded at $36.01, with a volume of 643.18K. It is down -3.12% in the last 24 hours and down -11.98% over the past month. Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.

Previous Close:

$37.17

Open:

$37.83

24h Volume:

643.18K

Relative Volume:

0.57

Market Cap:

$2.11B

Revenue:

$13.05M

Net Income/Loss:

$-60.54M

P/E Ratio:

-31.04

EPS:

-1.16

Net Cash Flow:

$-37.82M

1W Performance:

-0.99%

1M Performance:

-11.98%

6M Performance:

-19.80%

1Y Performance:

+174.05%

1-Day Range:

$35.53

$38.42

1-Week Range:

$35.53

$38.42

52-Week Range:

$13.20

$71.71

Janux Therapeutics Inc Stock (JANX) Company Profile

Name

Janux Therapeutics Inc

Sector

Healthcare (1169)

Industry

Biotechnology (678)

Phone

(858) 751-4493

Address

10955 VISTA SORRENTO PARKWAY, SAN DIEGO

Employee

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

JANX's Discussions on Twitter

Compare JANX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
JANX Janux Therapeutics Inc	36.01	2.11B	13.05M	-60.54M	-37.82M	-1.16
VRTX Vertex Pharmaceuticals Inc	484.24	124.35B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	700.33	76.56B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	644.48	39.16B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	250.59	32.44B	2.25B	-278.16M	-42.59M	-2.17
BNTX Biontech Se Adr	120.01	28.77B	3.30B	-501.07M	1.03B	-2.1146

Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-03-24	Reiterated	BTIG Research	Buy
Dec-03-24	Reiterated	H.C. Wainwright	Buy
Nov-22-24	Initiated	Leerink Partners	Outperform
Oct-24-24	Initiated	UBS	Buy
Sep-06-24	Initiated	Stifel	Buy
May-30-24	Initiated	Scotiabank	Sector Perform
Mar-21-24	Initiated	BTIG Research	Buy
Mar-20-24	Initiated	Cantor Fitzgerald	Overweight
Apr-06-23	Initiated	Wedbush	Outperform
Nov-14-22	Initiated	William Blair	Outperform

View All

Janux Therapeutics Inc Stock (JANX) Latest News

Feb 17, 2025

Trend Tracker for (JANX) - Stock Traders Daily

Feb 17, 2025

Feb 16, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Lester Murray Antman dba SimplyRich - MarketBeat

Feb 16, 2025

Feb 13, 2025

abrdn plc Acquires New Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX) - MarketBeat

Feb 13, 2025

Feb 12, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $89.90 Average PT from Analysts - MarketBeat

Feb 12, 2025

Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $89.90 Average Price Target from Brokerages - Defense World

Feb 12, 2025

Feb 10, 2025

Quarterly Snapshot: Quick and Current Ratios for Janux Therapeutics Inc (JANX) - The Dwinnex

Feb 10, 2025

Mid-Cap Biopharma’s Biggest Winners And Losers Of 2024 - insights.citeline.com

Feb 10, 2025

Feb 09, 2025

Andrew Hollman Meyer Sells 3,334 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock - MarketBeat

Feb 09, 2025

Janux Therapeutics (NASDAQ:JANX) Stock Price Up 6.9%Still a Buy? - MarketBeat

Feb 09, 2025

Janux Therapeutics (NASDAQ:JANX) Shares Down 4.2%Here's Why - MarketBeat

Feb 09, 2025

Feb 08, 2025

Janux Therapeutics Inc (NASDAQ: JANX) Gain Of 80.16% Compared To 52-Week Low; YTD Fall -26.47% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel

Feb 08, 2025

Feb 07, 2025